Core Laboratories N.V. chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 10.57
Dividend & Yield0.04$ (0.15%)
Beta 2.65
Market capitalization 1.24B
Operating cash flow 24.96M
ESG Scores unknown

Company description

Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, hydrogen storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. The company was founded in 1936 and is based in Amstelveen, the Netherlands.

Sector: Energy - Industry: Oil & Gas Equipment & Services

Financial Ratios
Quick Ratio1.58
Working Capital0.2
Return On Equity0.13
Debt To Equity1.24
Fixed Asset Ratio0.02
Fixed Interest Cover4.51

Financial data

Financial Statements

Cashflow Statement 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Change To Liabilities -9.27M -20.76M 8.88M 13.55M
Total Cashflows From Investing Activities -5.68M 7.85M -10.22M -3.86M
Net Borrowings 15M -46M -71M -15M
Total Cash From Financing Activities -85.87M -63.01M -22.46M -23.38M
Change To Operating Activities 8.65M -21.19M -11.37M -13.63M
Issuance Of Stock 60M 60M 60M
Net Income 101.98M -97.64M 19.73M 19.45M
Change In Cash -2.02M 2.71M 3.9M -2.27M
Effect Of Exchange Rate
Total Cash From Operating Activities 89.53M 57.87M 36.58M 24.96M
Depreciation 22.61M 20.87M 18.52M 17.16M
Change To Account Receivables -3.19M 46.42M -13.52M -10.08M
Other Cashflows From Financing Activities 8k -1.77M -1.37M -2.62M
Change To Netincome -27.35M 128.7M 18.9M 13.36M
Capital Expenditures -22.27M -11.88M -13.54M -10.22M

Income Statement 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Research Development
Income Before Tax 81.99M -91.18M 36.11M 29.95M
Net Income 101.98M -97.64M 19.73M 19.45M
Selling General Administrative 46.52M 32.53M 43.87M 37.57M
Gross Profit 172.63M 102.12M 102.36M 96.08M
Ebit 102.02M 49.63M 41.3M 43.05M
Operating Income 102.02M 49.63M 41.3M 43.05M
Interest Expense -14.69M -14.37M -9.15M -11.57M
Income Tax Expense -12.29M 5.9M 15.89M 10.3M
Total Revenue 668.21M 487.27M 470.25M 489.74M
Cost Of Revenue 495.58M 385.14M 367.9M 393.65M
Total Other Income ExpenseNet -20.02M -140.8M -5.19M -13.1M
Net Income From Continuing Ops 94.28M -97.07M 20.22M 19.66M
Net Income Applicable To Common Shares 101.98M -97.64M 19.73M 19.45M

Balance Sheet Statement 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Total Liabilities 592.53M 493.01M 419.85M 389.4M
Total Stockholder Equity 177.87M 71.51M 156.45M 184.26M
Other Current Liabilities 29.09M 22.2M 21.95M 17.34M
Total Assets 774.67M 568.58M 580.85M 578.35M
Common Stock 1.15M 1.15M 1.19M 1.19M
Other Current Assets 5.92M 6.23M 5.11M 5.06M
Retained Earnings 160.54M 50.46M 68.35M 85.95M
Treasury Stock -35.69M -21.27M -14.21M -5.14M
Cash 11.09M 13.81M 17.7M 15.43M
Total Current Liabilities 111.59M 89.75M 90.78M 103.14M
Other Stockholder Equity -6.33M -7.2M -10.13M -3.78M
Property, Plant, and Equipment 199.2M 181.68M 172.34M 157.41M
Total Current Assets 221.24M 165.85M 189.06M 211.7M
Net Tangible Assets -53.01M -36.52M 48.87M 77.33M
Net Receivables 138.11M 92.87M 106.74M 115.1M
Accounts Payable 35.61M 23.03M 29.73M 45.85M


Insider Transactions

Here are the insider transactions of stock shares related to Core Laboratories N.V.:

Filer Name Transaction Text Ownership Date Filer Relation Shares
HILL CHRISTOPHER SCOTTD2022-12-30Chief Financial Officer31.69k
BRUNO LAWRENCED2022-12-30Chief Executive Officer91.21k
DANIELS KEVIND2022-12-30Officer and Treasurer6k
GRESHAM GWENDOLYN YD2022-12-30Officer12k
DANIELS KEVIND2022-12-01Officer and Treasurer140
TATTOLI MARK DAMIAND2022-12-01General Counsel160
TATTOLI MARK DAMIAND2022-09-30General Counsel700
TATTOLI MARK DAMIAND2022-08-01General Counsel370
TATTOLI MARK DAMIAND2022-04-29General Counsel450
STRAUGHEN MICHAELD2022-04-01Director4.31k
CARNES MARTHA ZD2022-04-01Director4.31k
BARNETT GREGORY BARRYD2022-04-01Director4.31k
VAN DIJKEN EEUWIJK MONIQUED2022-04-01Director4.31k
KLINGENSMITH HARVEY ROBERTD2022-04-01Director4.31k
TEMENG KWAKUD2022-04-01Director4.31k
DANIELS KEVIND2022-03-01Officer and Treasurer120
TATTOLI MARK DAMIAND2022-03-01General Counsel110
HILL CHRISTOPHER SCOTTD2021-12-31Chief Financial Officer23.53k
BRUNO LAWRENCED2021-12-31Chief Executive Officer46.23k
DANIELS KEVIND2021-12-31Officer and Treasurer3.8k
SCHREFFLER GWENDOLYN Y.D2021-12-31Officer4.7k
DANIELS KEVIND2021-12-01Officer and Treasurer140
TATTOLI MARK DAMIAND2021-12-01General Counsel160
TATTOLI MARK DAMIAND2021-10-01General Counsel700
TATTOLI MARK DAMIAND2021-10-01General Counsel820
DANIELS KEVIND2021-07-01Officer and Treasurer105
VAN KEMPEN MARGARET ANND2021-04-01Director14.51k
STRAUGHEN MICHAELD2021-04-01Director14.51k
CARNES MARTHA ZD2021-04-01Director14.51k
BARNETT GREGORY BARRYD2021-04-01Director14.51k
VAN DIJKEN EEUWIJK MONIQUED2021-04-01Director14.51k
KLINGENSMITH HARVEY ROBERTD2021-04-01Director14.51k
DANIELS KEVIND2021-03-01Officer and Treasurer120
ELVIG MARK FD2020-12-31General Counsel2.6k
HILL CHRISTOPHER SCOTTD2020-12-31Chief Financial Officer2.6k
BRUNO LAWRENCED2020-12-31Chief Executive Officer13.68k
DANIELS KEVIND2020-12-31Officer and Treasurer2.6k
DANIELS KEVIND2020-12-01Officer and Treasurer140
DANIELS KEVIND2020-07-01Officer and Treasurer105
SODDERLAND JAN WILLEMPurchase at price 17.07 per share.D2020-05-07Director600
SODDERLAND JAN WILLEMD2020-04-01Director2.18k
VAN KEMPEN MARGARET ANND2020-04-01Director2.18k
HILL CHRISTOPHER SCOTTD2020-04-01Chief Financial Officer53
STRAUGHEN MICHAELD2020-04-01Director2.18k
CARNES MARTHA ZD2020-04-01Director2.18k
GOLDMAN SACHS GROUP INC.Purchase at price 9.25 - 9.41 per share.I2020-04-01Beneficial Owner of more than 10% of a Class of Security676
BRUNO LAWRENCED2020-04-01President100
DANIELS KEVIND2020-04-01Officer and Treasurer70
BARNETT GREGORY BARRYD2020-04-01Director2.18k
DANIELS KEVIND2020-02-28Officer and Treasurer120
BRUNO LAWRENCEPurchase at price 34.60 - 35.00 per share.D2020-02-03President3k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Core Laboratories N.V.. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Core Laboratories N.V.

Here is the result of two systematic investment strategies applied to Core Laboratories N.V.. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Core Laboratories N.V.

The following chart shows the equity curve of the two systematic investment strategies applied to Core Laboratories N.V.:

Core Laboratories N.V. automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -17.67% on the backtest period.

Performance at glance

Performance

-17.67 %

Latent gain

-391.06 $

Invested capital

2212.79 $

Annualized return

-4.27 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Core Laboratories N.V.

This is the result of two momentum investment strategies applied to Core Laboratories N.V.. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Core Laboratories N.V.

The following chart shows all the entries opened by the momentum investment system on Core Laboratories N.V.:

Core Laboratories N.V. momentum entries
  • The first momentum investment strategy would give -16.47% of return on Core Laboratories N.V.. That represents -723.51$ of latent gain with 4394.16$ of employed capital.
  • The second momentum investment strategy would give -26.16% of return on Core Laboratories N.V.. That represents -568.3$ of latent gain with 2172.51$ of employed capital.
Performance at glance (1Q Momentum)

Performance

-16.47 %

Latent gain

-723.51 $

Invested capital

4394.16 $

Annualized return

11.24 %
Performance at glance (2Q Momentum)

Performance

-26.16 %

Latent gain

-568.3 $

Invested capital

2172.51 $

Annualized return

-7.15 %

Momentum equity curve on Core Laboratories N.V.

The following chart shows the equity curve of the two momentum strategies applied to Core Laboratories N.V.:

Core Laboratories N.V. momentum equity

Note: the dividends potentially given by Core Laboratories N.V. are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Core Laboratories N.V.

The following chart shows the employed capital evolution of the two momentum strategies on Core Laboratories N.V. since the beginning:

Core Laboratories N.V.

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Core Laboratories N.V.

Buy the dip entry openings on Core Laboratories N.V.

Core Laboratories N.V.

The performance achieved by the robo-advisor on Core Laboratories N.V. is 24.05%. That represents 358.47$ of latent gain with 1490.45$ of employed capital. The following chart shows Core Laboratories N.V. stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Core Laboratories N.V., and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

24.05 %

Latent gain

358.47 $

Invested capital

1490.45 $

Annualized return

11.24 %

Equity curve of the strategy applied to Core Laboratories N.V.

The following chart shows the result of the investment strategy applied to Core Laboratories N.V.:

Core Laboratories N.V.

Note: the dividends potentially given by Core Laboratories N.V. are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Core Laboratories N.V.

The following chart shows the employed capital evolution since the beginning of the investment strategy on Core Laboratories N.V.:

Core Laboratories N.V.

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Core Laboratories N.V.

In this section, I will compare the three previous investment strategies applied to Core Laboratories N.V..

Equity curve comparison on Core Laboratories N.V.

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Core Laboratories N.V. investment strategy comparison

Employed capital comparison on Core Laboratories N.V.

Core Laboratories N.V. investment comparison

Performance comparison on Core Laboratories N.V.

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -17.67% -391.06$ 2212.79$ -4.27%
Momentum 1 quarter -16.47% -723.51$ 4394.16$ -4.22%
Momentum 2 quarters -26.16% -568.3$ 2172.51$ -7.15%
Non-directional 24.05% 358.47$ 1490.45$ 11.24%
Annualized return comparison

Automatic investment

-4.27 %

Momentum 1Q

-7.15 %

Momentum 2Q

-7.15 %

Non-directional

11.24 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Core Laboratories N.V.:

Positive correlations

Most correlated stocks this year

  • Core Laboratories N.V.

  • Most correlated stocks last 3 months

  • Stanley Black & Decker Inc - Unit
  • Forrester Research Inc
  • First Bancorp Inc (ME)
  • WYNNSTAY GROUP PLC ORD 25P
  • L.B. Foster Co. - Class A
  • Diamond Hill Investment Group Inc - Class A
  • Resolute Forest Products Inc
  • Universal Insurance Holdings Inc
  • Tupperware Brands Corporation
  • WestRock Company
  • Standard Motor Products Inc
  • Arrow Financial Corp
  • Luther Burbank Corp
  • Insteel Industries Inc
  • Matthews International Corp - Class A
  • Stanley Black & Decker Inc
  • First Foundation Inc
  • Verizon Communications Inc
  • Freeport-McMoRan Inc
  • Crocs Inc
  • Oppenheimer Holdings Inc - Class A
  • Topgolf Callaway Brands Corp
  • Core Laboratories N.V.
  • Global X SuperDividend ETF
  • Universal Stainless & Alloy Products Inc
  • Snap-on Inc
  • INVESCO INTERNATIONAL BUYBACK ACHIEVERS ETF
  • UMH Properties Inc
  • IShares MSCI Emerging Markets ex China ETF
  • Capri Holdings Ltd
  • Hasbro Inc
  • iShares MSCI Ireland ETF
  • Franklin Electric Co. Inc
  • Universal Corp
  • Curtiss-Wright Corp
  • WEIR GROUP PLC ORD 12.5P
  • Lincoln Electric Holdings Inc
  • Autoliv Inc
  • LyondellBasell Industries NV - Class A
  • Emerson Electric Company
  • JELD-WEN Holding Inc
  • Encore Wire Corp
  • DXP Enterprises Inc
  • First Bancorp PR
  • Forward Air Corp
  • Mosaic Company
  • Mueller Industries Inc
  • Invesco S&P SmallCap Materials ETF
  • Invesco S&P 500 Equal Weight Materials ETF
  • Invesco S&P SmallCap 600 Pure Value ETF
  • Scansource Inc
  • ITT Inc
  • Robert Half International Inc
  • Avient Corp
  • Whirlpool Corp
  • J.B. Hunt Transport Services Inc
  • MACOM Technology Solutions Holdings Inc
  • Paccar Inc
  • TE Connectivity Ltd
  • Donaldson Co. Inc
  • Oxford Industries Inc
  • Sensient Technologies Corp
  • Sierra Bancorp
  • Trico Bancshares
  • O-I Glass Inc
  • Ingevity Corp
  • Invesco S&P SmallCap Information Technology ETF
  • Kaman Corp
  • PPG Industries Inc
  • Flowserve Corp
  • VICTORYSHARES INTERNATIONAL HIGH DIV VOLATILITY WT
  • First Trust RiverFront Dynamic Developed Internati
  • Vanguard International High Dividend Yield ETF
  • VICTORYSHARES INTERNATIONAL VOLATILITY WTD ETF
  • Schwab International Equity ETF
  • SPDR Portfolio Developed World ex-US ETF
  • Crane Holdings Company
  • AGCO Corp
  • Marriott International Inc - Class A
  • Sonoco Products Company
  • iShares Trust iShares ESG Aware MSCI EAFE ETF
  • Vishay Precision Group Inc
  • Barrett Business Services Inc
  • Summit Materials Inc - Class A
  • Clearfield Inc
  • Minerals Technologies Inc
  • American Vanguard Corp
  • Trimas Corporation
  • Innospec Inc
  • Myers Industries Inc
  • Acuity Brands Inc
  • Miller Industries Inc
  • Canadian National Railway Company
  • Hibbett Inc
  • Fortive Corp
  • Genpact Ltd
  • Arlo Technologies Inc
  • ISHARES INDIA 50 ETF
  • Woori Financial Group Inc
  • Shinhan Financial Group Co. Ltd
  • DZS Inc
  • iMedia Brands Inc - Class A
  • Rush Enterprises Inc - Class A
  • Rush Enterprises Inc - Class B
  • JAGUAR MINING INC
  • H.B. Fuller Company
  • CRH Plc
  • H&E Equipment Services Inc
  • Fabrinet
  • Gap Inc
  • Invesco RAFI Strategic Developed ex-US ETF
  • Rigel Pharmaceuticals
  • Pediatrix Medical Group Inc
  • Liberty TripAdvisor Holdings Inc - Series A
  • Almaden Minerals Ltd
  • Equitrans Midstream Corporation
  • Graham Holdings Co. - Class B
  • POSCO Holdings Inc
  • Valvoline Inc
  • Deere & Company
  • Radware
  • CGI Inc - Class A
  • Titan Machinery Inc
  • Maximus Inc
  • 3M Company
  • Leggett & Platt Inc
  • Union Pacific Corp
  • Armada Hoffler Properties Inc
  • Cactus Inc - Class A
  • Hudbay Minerals Inc
  • Mettler-Toledo International Inc

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months


    Note: The algorithm computes the probability of correlation between Core Laboratories N.V. and the other stocks. There may be false positives or some missing correlated stocks. If the price of Core Laboratories N.V. does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name Core Laboratories N.V.
    Country Netherlands
    City Amstelveen
    Address Van Heuven Goedhartlaan 7 B
    Phone 31 20 420 3191
    Website www.corelab.com
    FullTime employees 3600
    Industry Oil & Gas Equipment & Services
    Sector Energy
    Exchange XNYS
    Ticker CLB
    Market www.nyse.com

    Core Laboratories N.V. ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown